caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1851300826

Maurice MosseriM.D.

PRACTICEGLAUCOMA MEDICAL CONSULTANTS OF NEW YORK, PLLCSee all providers at this practice →
OphthalmologyBrooklyn, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Maurice Mosseri's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Bioreference Health, Llc
Clinical Laboratory · Elmwood Park, NJ
40124
Lenco Diagnostic Laboratories,inc.
Clinical Laboratory · Brooklyn, NY
2235
MAIMONIDES MEDICAL CENTER2136
Quality Healthcare Management Inc
Clinical Laboratory · Brooklyn, NY
1452
Yoon Kim
Optometry · Flushing, NY
1419
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
1336
Steven Ali
Optometry · Flushing, NY
1213
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
2,387
Unique beneficiaries
—
Total services
4,026
Distinct HCPCS
22
Medicare payment
$292K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,438 Ophthalmology providers in NY — above median (cohort median 1,869).
PRESCRIBING · PART D · 2024
Total Rx claims
3,311
Beneficiaries
—
Total drug cost
$339K
Distinct drugs
27
Brand share
31.4%
Top prescribed drugs
Latanoprost987 claims
Brimonidine Tartrate317 claims
Dorzolamide Hcl/Timolol Maleat316 claims
Prednisolone Acetate191 claims
Difluprednate185 claims
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
94.3
Cost
0.0
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
1.05%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$760
Payment records
39
By payment type
Food and Beverage$760